AstraZeneca’s US listing to leave £200mn UK stamp duty hole

All NewsOctober 2, 2025

HMRC will no longer reap benefit of share trading in FTSE 100’s largest company

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent